Vashtie Ramjattan
Acute Care · New Brunswick, NJNPI 1619398948
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,925 of the $5,705 with a category attached, or 86.3%. 31 manufacturers reported payments, led by Boston Scientific at 38.4% of the total. Among acute care clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 178 payments — averaging $32.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- E.r. Squibb & Sons, L.L.C.$575
- Abbott$448
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$293
- Medtronic$284
- AstraZeneca$273
- plus $2K from 25 others
What the payments were for
- Travel & lodging$78014%
- Food & beverage$4,92586%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 33 | $2,193 |
| E.r. Squibb & Sons, L.L.C. | 20 | $575 |
| Abbott | 21 | $448 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $293 |
| Medtronic | 14 | $284 |
| AstraZeneca | 6 | $273 |
| Abiomed | 6 | $234 |
| Boehringer Ingelheim | 5 | $183 |
| Edwards Lifesciences | 2 | $159 |
| Lantheus Medical Imaging, Inc. | 6 | $124 |
| Alnylam Pharmaceuticals Inc. | 2 | $114 |
| Merck | 7 | $102 |
| Pfizer | 6 | $90 |
| Johnson & Johnson | 6 | $88 |
| Cvrx, Inc. | 4 | $66 |
| Biosense Webster, Inc. | 2 | $59 |
| Kestra Medical Technology Services, Inc. | 3 | $53 |
| Scpharmaceuticals Inc. | 2 | $52 |
| Esperion Therapeutics, Inc. | 3 | $44 |
| Amgen | 3 | $44 |
| Novartis | 2 | $34 |
| CSL Behring | 1 | $31 |
| Amarin Pharma, Inc. | 2 | $28 |
| Atricure, Inc. | 1 | $21 |
| Impulse Dynamics (USA) Inc. | 1 | $21 |
| Chiesi USA, Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
| La Jolla Pharmaceutical Company | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$1,269
- WATCHMAN FLX$276
- SAPIEN 3 Ultra RESILIA$135
- ELIQUIS$125
- JARDIANCE$125
- WAINUA$125
- LUX-Dx Insertable Cardiac Monitor$122
How this compares
$5,705 in reported general payments places this provider in the 95th percentile of 656 acute care providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 17 | $183 |
| Atorvastatin Calcium | 13 | $94 |
Paid to pharmacies, not to this prescriber.
Other acute care in New Brunswick
- Sally CascioNew Brunswick$12K
- Ester CaballeroNew Brunswick$7K
- Amita AvadhaniNew Brunswick$4K
- Jodelle GoldNew Brunswick$3K
- Gabriella MagarelliHackensack$44K
- Per RosenkvistLivingston$29K
- Matthew OstroffPaterson$27K
- Ellen McCueNeptune$26K
- Suzanne ShuggLivingston$25K
- Maria Tedi CoronelHackensack$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.